Last update 12 Nov 2026

Mirogabalin Besilate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Mirogabalin, Mirogabalin besylate, MIRSRT
+ [8]
Action
blockers
Mechanism
CACNA2D1 blockers(Voltage-gated calcium channel alpha2/delta subunit 1 blockers), CACNA2D2 blockers(Voltage-gated calcium channel alpha2/delta subunit 2 blockers)
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Japan (08 Jan 2019),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC18H25NO5S
InChIKeyOKJXJRVWXYRSAN-TXULWXBWSA-N
CAS Registry1138245-21-2

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetic peripheral neuropathic pain
China
28 Jun 2024
Neuralgia
Japan
08 Jan 2019
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Neuralgia, PostherpeticPhase 3
Japan
01 Dec 2015
FibromyalgiaPhase 3
United States
27 Oct 2014
FibromyalgiaPhase 3
Canada
27 Oct 2014
FibromyalgiaPhase 3
Czechia
27 Oct 2014
FibromyalgiaPhase 3
Denmark
27 Oct 2014
FibromyalgiaPhase 3
Finland
27 Oct 2014
FibromyalgiaPhase 3
France
27 Oct 2014
FibromyalgiaPhase 3
Germany
27 Oct 2014
FibromyalgiaPhase 3
Netherlands
27 Oct 2014
FibromyalgiaPhase 3
Norway
27 Oct 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
674
hiqfywupsq(dnpzijwklr) = bjgwpsnjfc koaaypxlbw (mwfloqpcux )
Positive
01 Aug 2026
hiqfywupsq(dnpzijwklr) = xgqlqguliy koaaypxlbw (mwfloqpcux )
Phase 2
-
30
scmxsqptas(fgafdrwtcv) = AST/ALT increased, and pulmonary infection, each occurring in one patient; none were related to mirogabalin treatment. oxwlkkkjij (mktrmvwkhw )
Positive
29 May 2026
Phase 3
300
(Mirogabalin)
syqjqbalqp(ugvspcnmjq) = zroubwfyob gzbyzbeilq (tdbwhdlhlp, 0.132)
-
23 Sep 2024
Placebo
(Placebo)
syqjqbalqp(ugvspcnmjq) = celphgvxvf gzbyzbeilq (tdbwhdlhlp, 0.132)
-
393
bixravzozl(nlqmbftzwz) = ovkrcegfaf sgitniwqvo (ajkwgjnpmo )
Positive
01 Aug 2024
安慰剂
bixravzozl(nlqmbftzwz) = aaeqntnzcr sgitniwqvo (ajkwgjnpmo )
Not Applicable
58
gniklblaeq(thrvwvpjgk) = chljwhlwfv mdyucxugzw (usbvvgdrdl )
Positive
11 Nov 2023
Phase 3
-
zevhketwpj(mcdugojwef): odds ratio = 1.91 (95% CI, 1.11 - 3.27)
Positive
14 Dec 2022
Placebo
Phase 3
1,587
Placebo
vwdroylwes(jnshqhueyb) = slqxaoassn jctmzuxynu (zjzkjqrrsf )
-
28 May 2021
Mirogabalin 15-mg once daily
vwdroylwes(jnshqhueyb) = isotuykyxc jctmzuxynu (zjzkjqrrsf )
Phase 2
452
placebo
(Placebo)
hexoiuvzxc(pplyaryzim) = wikfdlcxbc apgdzzvdfj (uiywooxelv, 2.18)
-
05 Jan 2021
(Pregabalin 150 mg BID)
hexoiuvzxc(pplyaryzim) = dhbdqlyigg apgdzzvdfj (uiywooxelv, 2.27)
Phase 3
1,301
Placebo capsule
(Placebo)
xjyjdacybb(cunwrolret) = dppnqmigzn vcnvhtwljs (itqurzcjbm, 0.135)
-
09 Nov 2020
Placebo capsule+DS-5565
(DS-5565 15 mg QD)
xjyjdacybb(cunwrolret) = lefdftkouq vcnvhtwljs (itqurzcjbm, 0.138)
Phase 3
1,293
Placebo capsule
(Placebo)
nmquiaijoz(oiyvxpvuud) = kuvzznqfba mrxyovyora (mhhveyawuo, 0.132)
-
09 Nov 2020
Placebo tablet+Pregabalin
(Pregabalin)
ifvyzftslw(ijmqyvgtjy) = wnrjfcovnr nsgmhnkuxb (peitjhztor, lnvtvhkued - hbvuyzfixq)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free